Approval · Notice of Compliance 16594 · 2015
ZILMAX: Notice of Compliance 16594
Issued February 12, 2015
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 16594
- Date
- February 12, 2015
- Company
- Intervet Canada CorpKirkland, Quebec, Canada
- Product type
- Veterinary
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Additions to dosage and administration section
- Therapeutic class
- Beta2-adrenergic agoniste
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ZILMAX | 02324121 | Dormant |
Medicinal ingredients
- ZILPATEROL HYDROCHLORIDE 48 G per KG